Clinical Characteristics and Outcomes Among COVID-19 Hospitalized Patients with Chronic Conditions: A Retrospective Single-Center Study

References

• Lee A. Wuhan novel coronavirus (COVID-19): why global control is challenging? Public Health. 2020;179:A1. doi:10.1016/j.puhe.2020.02.001
   PubMed Web of Science ®Google Scholar
• Yang L, Liu J, Zhang R, et al. Epidemiological and clinical features of 200 hospitalized patients with corona virus disease 2019 outside Wuhan, China: a descriptive study [published online ahead of print, 2020 May 26]. J Clin Virol. 2020;129:104475. doi:10.1016/j.jcv.2020.104475
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Chow N, Fleming-Dutra K, Gierke R; CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(13):382–386. doi:10.15585/mmwr.mm6913e2
   PubMed Web of Science ®Google Scholar
• Barry M, Ghonem L, Alsharidi A, et al. Coronavirus Disease‑2019 Pandemic in the Kingdom of Saudi Arabia: mitigation measures and hospital preparedness. J Nat Sci Med. 2020;3(3):155–158.
   Google Scholar
• Barry M, Al Amri M, Memish ZA. COVID-19 in the shadows of MERS-CoV in the Kingdom of Saudi Arabia. J Epidemiol Glob Health. 2020;10(1):1–3. doi:10.2991/jegh.k.200218.003
   PubMed Web of Science ®Google Scholar
• Al Otaibi AM, Kattan WM, Nabil AM. The impact of Saudi (CBAHI) accreditation on enhancing patient safety and improvingthe quality of care indicators. Prensa Med Argent. 2020;106:3.
   Google Scholar
• Barry M, Ghonem L, Alsharidi A, et al. Coronavirus Disease 2019 (COVID-19) pandemic in the Kingdom of Saudi Arabia: mitigation measures and hospitals preparedness. J Nat Sci Med. 2020;1.
   Google Scholar
• Al-Mandhari A, Samhouri D, Abubakar A, Brennan R. Coronavirus Disease 2019 outbreak: preparedness and readiness of countries in the Eastern Mediterranean Region. East Mediterr Health J. 2020;26(2):136–137. doi:10.26719/2020.26.2.136
   Web of Science ®Google Scholar
• Thng ZX, De Smet MD, Lee CS, et al. COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs. Br J Ophthalmol. 2020;bjophthalmol-2020-316586. doi:10.1136/bjophthalmol-2020-316586.
   PubMed Web of Science ®Google Scholar
• Alsofayan YM, Althunayyan SM, Khan AA, Hakawi AM, Assiri AM. Clinical characteristics of COVID-19 in Saudi Arabia: a national retrospective study. J Infect Public Health. 2020;13(7):920–925. doi:10.1016/j.jiph.2020.05.026
   PubMed Web of Science ®Google Scholar
• Bridgewood C, Damiani G, Sharif K, et al. Rationale for evaluating PDE4 inhibition for mitigating against severe inflammation in COVID-19 Pneumonia and beyond. Isr Med Assoc J. 2020;22(6):335–339.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US). How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon General. Atlanta (GA): centers for disease control and prevention (US); 2010. Available from: https://www.ncbi.nlm.nih.gov/books/NBK53017/. Accessed June 17, 2020.
   Google Scholar
• NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–2642. doi:10.1016/S0140-6736(17)32129-3.
   PubMed Web of Science ®Google Scholar
• Guideline of American Diabetes Association. Standards of medical care in diabetes–2015: summary of revisions. Diabetes Care. 2015;(38 Suppl):S4. doi:10.2337/dc15-S003
   Web of Science ®Google Scholar
• Son JS, Choi S, Lee G, et al. Blood pressure change from normal to 2017 ACC/AHA defined stage 1 hypertension and cardiovascular risk. J Clin Med. 2019;8(6):820. doi:10.3390/jcm8060820
   Web of Science ®Google Scholar
• Chang D, Lin M, Wei L, et al. Epidemiologic and clinical characteristics of Novel Coronavirus infections involving 13 patients outside Wuhan, China. JAMA. 2020;323(11):1092–1093. doi:10.1001/jama.2020.1623
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730–1741. doi:10.1111/all.14238
   PubMed Web of Science ®Google Scholar
• Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of Novel Coronavirus-infected Pneumonia. N Engl J Med. 2020;382(13):1199–1207. doi:10.1056/NEJMoa2001316
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Lauer SA, Grantz KH, Bi Q, et al. The incubation period of Coronavirus Disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577–582. doi:10.7326/M20-0504
   PubMed Web of Science ®Google Scholar
• Saad M, Omrani AS, Baig K, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis. 2014;29:301–306. doi:10.1016/j.ijid.2014.09.003
   PubMed Web of Science ®Google Scholar
• Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547. doi:10.1183/13993003.00547-2020
   PubMed Web of Science ®Google Scholar
• Eurosurveillance Editorial Team. Updated rapid risk assessment from ECDC on coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK. Euro Surveill. 2020;25(12):2003121. doi:10.2807/1560-7917.ES.2020.25.12.200326.
   Google Scholar
• Montero F, Martínez-Barrio J, Serrano-Benavente B, et al. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes. Rheumatol Int. 2020;1–6.
   Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi:10.1001/jama.2020.1585
   PubMed Web of Science ®Google Scholar
• Sohrabi C, Alsafi Z, O’Neill N, et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020;76:71–76. doi:10.1016/j.ijsu.2020.02.034
   PubMed Web of Science ®Google Scholar
• Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95. doi:10.1016/j.ijid.2020.03.017
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Harapan H, Itoh N, Yufika A, et al. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 2020;13(5):667–673. doi:10.1016/j.jiph.2020.03.019
   PubMed Web of Science ®Google Scholar
• Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang X, Jia X, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020;26(6):767–772. doi:10.1016/j.cmi.2020.04.012
   PubMed Web of Science ®Google Scholar
• Qiu J, Ma J, Zhang S, Han J, Liu S. Promoting platelets is a therapeutic option to combat severe viral infection of the lung. Blood Adv. 2020;4(8):1640–1642. doi:10.1182/bloodadvances.2020001669
   Web of Science ®Google Scholar
• Lippi G, Mattiuzzi C. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematol Transfus Cell Ther. 2020;42(2):116–117. doi:10.1016/j.htct.2020.03.001
   PubMedGoogle Scholar
• Tran VT, Ravaud P. COVID-19–related perceptions, context and attitudes of adults with chronic conditions: results from a cross-sectional survey nested in the ComPaRe e-cohort. PLoS One. 2020;15(8):e0237296.
   Web of Science ®Google Scholar